REG - Craneware plc - Change of Date of Final Results

CranewareAnnouncement

14/09/2022 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220914:nRSN4898Za&default-theme=true

RNS Number : 4898Z  Craneware plc  14 September 2022

Craneware plc

("Craneware", the "Craneware Group", the "Company" or the "Group")

 

Change of Date of Final Results

 

14 September 2022 - Craneware (AIM: CRW.L), the market leader in Value Cycle
solutions for the US healthcare market, announces that due to the State
Funeral of Her Majesty Queen Elizabeth II on 19(th) September 2022, it will
now announce its results for the year ended 30 June 2022 on Tuesday 20(th)
September.

 

 

 

For further information, please contact:

 

 Craneware plc                                               +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma (Financial PR)                                         +44 (0)20 3405 0205
 Caroline Forde, Hilary Buchanan, Joe Pederzolli             craneware@almapr.co.uk

 Peel Hunt (NOMAD and Joint Broker)                          +44 (0)20 7418 8900
 Dan Webster, Andrew Clark

 Investec Bank PLC (Joint Broker)                            +44 (0)20 7597 5970
 Patrick Robb, Henry Reast, Sebastian Lawrence
 ( )
 Berenberg (Joint Broker)                                    +44 (0)20 3207 7800
 Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff

 

 

About Craneware

 

We at the Craneware Group of companies, including our latest additions Sentry
Data Systems and Agilum Healthcare Intelligence, passionately believe we can
impact healthcare profoundly by delivering the insights healthcare
organizations need to also transform the business of healthcare. Our shared
vision is to be the operational and financial partner for U.S. healthcare
providers.

 

Our combined suite of applications and industry-leading team of experts help
our customers contextualize operational, financial, and clinical data,
providing insights that clearly demonstrate what great looks like. These value
cycle insights deliver revenue integrity and 340B compliance, as well as
margin and operational intelligence - something no other single partner can
provide.

 

Together, approximately 40% of registered U.S. hospitals are now our
customers, including more than 12,000 U.S hospitals, health systems and
affiliated retail pharmacies and clinics. Our customers are operating with a
financial impact of nearly half a trillion dollars. We have data sets from
customers covering more than 150 million unique patients encounters.

 

Learn more at www.thecranewaregroup.com (http://www.thecranewaregroup.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORZZLFFLKLLBBV